'Muskonomy' shakeup: SpaceX valuation approaches Tesla's after merger with xAI
cnbc.com
Want to monitor PLRX?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor PLRXpliant therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. by harnessing the therapeutic potential of integrin biology and tgf-β modulation, pliant aims to prevent or even reverse fibrosis to address the needs of many patients. the company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery.